S&P 500   3,390.99 (-2.15%)
DOW   27,631.63 (-2.48%)
QQQ   280.44 (-1.51%)
AAPL   114.54 (-0.43%)
MSFT   210.92 (-2.46%)
FB   280.15 (-1.63%)
GOOGL   1,596.24 (-2.25%)
AMZN   3,208.31 (+0.12%)
TSLA   417.00 (-0.86%)
NVDA   534.02 (-1.76%)
BABA   306.30 (-1.17%)
CGC   18.69 (-5.27%)
GE   7.39 (-3.15%)
MU   52.12 (-1.38%)
AMD   82.41 (+0.55%)
T   27.19 (-2.26%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.43 (-2.24%)
NFLX   484.28 (-0.82%)
NIO   26.24 (-3.39%)
BA   161.05 (-3.77%)
DIS   124.44 (-3.05%)
S&P 500   3,390.99 (-2.15%)
DOW   27,631.63 (-2.48%)
QQQ   280.44 (-1.51%)
AAPL   114.54 (-0.43%)
MSFT   210.92 (-2.46%)
FB   280.15 (-1.63%)
GOOGL   1,596.24 (-2.25%)
AMZN   3,208.31 (+0.12%)
TSLA   417.00 (-0.86%)
NVDA   534.02 (-1.76%)
BABA   306.30 (-1.17%)
CGC   18.69 (-5.27%)
GE   7.39 (-3.15%)
MU   52.12 (-1.38%)
AMD   82.41 (+0.55%)
T   27.19 (-2.26%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.43 (-2.24%)
NFLX   484.28 (-0.82%)
NIO   26.24 (-3.39%)
BA   161.05 (-3.77%)
DIS   124.44 (-3.05%)
S&P 500   3,390.99 (-2.15%)
DOW   27,631.63 (-2.48%)
QQQ   280.44 (-1.51%)
AAPL   114.54 (-0.43%)
MSFT   210.92 (-2.46%)
FB   280.15 (-1.63%)
GOOGL   1,596.24 (-2.25%)
AMZN   3,208.31 (+0.12%)
TSLA   417.00 (-0.86%)
NVDA   534.02 (-1.76%)
BABA   306.30 (-1.17%)
CGC   18.69 (-5.27%)
GE   7.39 (-3.15%)
MU   52.12 (-1.38%)
AMD   82.41 (+0.55%)
T   27.19 (-2.26%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.43 (-2.24%)
NFLX   484.28 (-0.82%)
NIO   26.24 (-3.39%)
BA   161.05 (-3.77%)
DIS   124.44 (-3.05%)
S&P 500   3,390.99 (-2.15%)
DOW   27,631.63 (-2.48%)
QQQ   280.44 (-1.51%)
AAPL   114.54 (-0.43%)
MSFT   210.92 (-2.46%)
FB   280.15 (-1.63%)
GOOGL   1,596.24 (-2.25%)
AMZN   3,208.31 (+0.12%)
TSLA   417.00 (-0.86%)
NVDA   534.02 (-1.76%)
BABA   306.30 (-1.17%)
CGC   18.69 (-5.27%)
GE   7.39 (-3.15%)
MU   52.12 (-1.38%)
AMD   82.41 (+0.55%)
T   27.19 (-2.26%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.43 (-2.24%)
NFLX   484.28 (-0.82%)
NIO   26.24 (-3.39%)
BA   161.05 (-3.77%)
DIS   124.44 (-3.05%)
Log in
NYSE:CVS

CVS Health Stock Forecast, Price & News

$58.89
-1.36 (-2.26 %)
(As of 10/26/2020 11:21 AM ET)
Add
Compare
Today's Range
$58.84
Now: $58.89
$59.97
50-Day Range
$56.71
MA: $58.78
$60.91
52-Week Range
$52.04
Now: $58.89
$77.03
Volume130,000 shs
Average Volume6.30 million shs
Market Capitalization$77.07 billion
P/E Ratio9.36
Dividend Yield3.38%
Beta0.68
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services. The company's Retail/LTC segment sells prescription drugs and general merchandise, such as over-the-counter drugs, beauty products, cosmetics, and personal care products, as well as provides health care services through its MinuteClinic walk-in medical clinics. Its Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management, Medicare plans, PDPs, Medicaid health care management services, workers' compensation administrative services, and health information technology products and services. The company's customers include employers, insurance companies, unions, government employee groups, health plans, Medicare Part D prescription drug plans, Medicaid managed care plans, plans offered on public health insurance exchanges and private health insurance exchanges, other sponsors of health benefit plans, individuals, college students, workers, labor groups, and expatriates. As of December 31, 2018, it had approximately 40 leased on-site pharmacies, 25 leased retail specialty pharmacy stores, 20 specialty mail order pharmacies, and 90 branches for infusion and enteral services; and 9,900 retail locations and 1,100 MinuteClinic locations, as well as operated an online retail pharmacy Websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Read More
CVS Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.2Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.41 out of 5 stars

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
CUSIP12665010
Phone401-765-1500
Employees290,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$256.78 billion
Cash Flow$10.40 per share
Book Value$49.33 per share

Profitability

Net Income$6.63 billion

Miscellaneous

Outstanding Shares1,308,700,000
Market Cap$77.07 billion
Next Earnings Date11/6/2020 (Confirmed)
OptionableOptionable
$58.89
-1.36 (-2.26 %)
(As of 10/26/2020 11:21 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CVS Health (NYSE:CVS) Frequently Asked Questions

How has CVS Health's stock price been impacted by Coronavirus?

CVS Health's stock was trading at $61.31 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CVS stock has decreased by 3.8% and is now trading at $58.97.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of CVS Health?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings, 12 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for CVS Health
.

When is CVS Health's next earnings date?

CVS Health is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for CVS Health
.

How can I listen to CVS Health's earnings call?

CVS Health will be holding an earnings conference call on Friday, November 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) posted its quarterly earnings data on Wednesday, August, 5th. The pharmacy operator reported $2.64 EPS for the quarter, beating the consensus estimate of $1.93 by $0.71. The pharmacy operator had revenue of $65.30 billion for the quarter, compared to analysts' expectations of $64.29 billion. CVS Health had a net margin of 3.13% and a return on equity of 16.32%. The firm's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.89 earnings per share.
View CVS Health's earnings history
.

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Wednesday, October 7th. Shareholders of record on Thursday, October 22nd will be paid a dividend of $0.50 per share on Monday, November 2nd. This represents a $2.00 annualized dividend and a dividend yield of 3.39%. The ex-dividend date of this dividend is Wednesday, October 21st.
View CVS Health's dividend history
.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health updated its FY20 earnings guidance on Tuesday, September, 15th. The company provided earnings per share guidance of $7.14-7.27 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.23.

What price target have analysts set for CVS?

17 brokers have issued 12-month price targets for CVS Health's stock. Their forecasts range from $66.00 to $104.00. On average, they expect CVS Health's stock price to reach $82.33 in the next year. This suggests a possible upside of 39.6% from the stock's current price.
View analysts' price targets for CVS Health
.

Has CVS Health been receiving favorable news coverage?

Press coverage about CVS stock has been trending neutral recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CVS Health earned a media sentiment score of 0.5 on InfoTrie's scale. They also gave media headlines about the pharmacy operator a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
View the latest news about CVS Health
.

Who are some of CVS Health's key competitors?

What other stocks do shareholders of CVS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), The Walt Disney (DIS), Johnson & Johnson (JNJ), NVIDIA (NVDA), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA) and Home Depot (HD).

Who are CVS Health's key executives?

CVS Health's management team includes the following people:
  • Mr. Larry J. Merlo, Pres, CEO & Director (Age 63)
  • Ms. Eva C. Boratto, Exec. VP & CFO (Age 52)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 63)
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel (Age 55)
  • Mr. Derica W. Rice, Exec. VP & Pres of CVS Caremark (Age 54)

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

Who are CVS Health's major shareholders?

CVS Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include LSV Asset Management (0.55%), Scharf Investments LLC (0.13%), Envestnet Asset Management Inc. (0.09%), Retirement Systems of Alabama (0.08%), Standard Life Aberdeen plc (0.06%) and Focused Investors LLC (0.06%). Company insiders that own CVS Health stock include Alan Lotvin, C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo, Troyen A Brennan and Vost Collin.
View institutional ownership trends for CVS Health
.

Which major investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including DAVENPORT & Co LLC, Adams Diversified Equity Fund Inc., Envestnet Asset Management Inc., Hexavest Inc., Ziegler Capital Management LLC, Standard Life Aberdeen plc, Scharf Investments LLC, and Redpoint Investment Management Pty Ltd. Company insiders that have sold CVS Health company stock in the last year include James David Clark, Jonathan C Roberts, Karen S Lynch, Larry J Merlo, and Troyen A Brennan.
View insider buying and selling activity for CVS Health
.

Which major investors are buying CVS Health stock?

CVS stock was bought by a variety of institutional investors in the last quarter, including Gateway Investment Advisers LLC, Assenagon Asset Management S.A., CWM LLC, Garland Capital Management Inc., LSV Asset Management, Avantax Advisory Services Inc., Douglas Lane & Associates LLC, and Sanders Morris Harris LLC. Company insiders that have bought CVS Health stock in the last two years include Alan Lotvin, C David Brown II, David W Dorman, and Edward J Ludwig.
View insider buying and selling activity for CVS Health
.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $58.97.

How big of a company is CVS Health?

CVS Health has a market capitalization of $77.17 billion and generates $256.78 billion in revenue each year. The pharmacy operator earns $6.63 billion in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 290,000 workers across the globe.

What is CVS Health's official website?

The official website for CVS Health is www.cvshealth.com.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]

This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.